← Back to all trials
Recruiting
NCT05682989
Efficacy/Safety of Urogynecology Synthetic Mesh Surgery
Conditions: Pelvic Organ Prolapse
Sex: Female
Ages: 30 Years – 100 Years
Enrollment: 150
Sponsor: Mackay Medical College
Location: Taiwan
Summary
This is a retrospective cohort study, aiming at analyzing the efficacy and safety of mesh surgery in pelvic organ prolapse.
The synthetic mesh for pelvic organ prolapse include transvaginal mesh or laparotomy, laparoscope, or robotic-assisted laparoscopic sacrocolpopexy with mesh augmentation.
The investigators would like to evaluate the efficacy and safety, such as recurrence rates and complication rates for women who underwent urogynecology mesh surgery.
Eligibility Criteria
Inclusion Criteria:Pelvic organ prolapse patients with objective / subjective voiding dysfunctionsUnderwent surgery for symptomatic POP ≥ stage II (POP-Q system)Exclusion Criteria:Patients with a history of pelvic radiation.Patients with a history of vesico-/recto-/urethra-vaginal fistulaPatients unable to be followed up.
Source: ClinicalTrials.gov (NCT05682989). StuddyBuddy aggregates publicly available trial information.